M Sadarangani, A Marchant… - Nature reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …
M Sadarangani, A Marchant… - Nature reviews …, 2021 - europepmc.org
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …
M Sadarangani, A Marchant… - Nature Reviews …, 2021 - ncbi.nlm.nih.gov
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …
M Sadarangani, A Marchant… - Nature Reviews …, 2021 - research-repository.uwa.edu.au
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …
M Sadarangani, A Marchant… - NAtuRe RevIeWs …, 2021 - edisciplinas.usp.br
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …
M Sadarangani, A Marchant… - Nature reviews …, 2021 - europepmc.org
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including …